We develop and commercialize innovative, clinically relevant diagnostic tools based on genetics.
Our products enable to:
Based on the most recent, validated knowledge in the field of health and genetics and proprietary algorithms.
10 December 2015
Gene Predictis SA, a Swiss precision medicine company offering tools to optimize drug treatments, is a winner of the European Venture Contest 2015. The company was selected from over 1’000 companies in high technology sector, by an international investors jury …
1 December 2015
Gene Predictis®, a Swiss precision medicine company, announces the closing of its first financing round. The company has raised CHF 0.5 million from a strategic investor that is a major player in the Swiss health care ecosystem. The proceeds will …